Prisys Biotechnologies

Biotechnology51-200 emp.
HQNanqiao, Shanghai, China
Founded2011 · EN
WebsiteLinkedIn

Unlock new drug development potential with innovative NHP technologies.

They run a cutting-edge CRO focused on enhancing drug transformation through advanced Non-Human Primate (NHP) technologies. Their expertise spans pharmacology, safety evaluation, and translational research, offering a robust platform for collaboration. By teaming up, users could tap into their innovative models and state-of-the-art facilities to accelerate research and development projects, driving breakthroughs in various disease areas. Explore the possibility of co-developing next-generation therapies together.